Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 5,977  64.00  1.06%   
About 61% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Panagora Asset Management Inc. Increases Stock Position in Teva Pharmaceutical Industries Limited - ...
Google News at Macroaxis
over six months ago at news.google.com         
Insider Sale Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ... - Ya...
Google News at Macroaxis
over six months ago at news.google.com         
New EVP, Teva Global Operations appointed - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited Stock Catapults 27 percent Though Its Price And Business Stil...
Google News at Macroaxis
over six months ago at news.google.com         
Should Value Investors Buy Teva Pharmaceutical Industries Stock - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceuticals Stock Has Unusual Call Options Activity After Its Q1 Results - Barchart
Google News at Macroaxis
over six months ago at news.google.com         
Teva Stock Rises as Schizophrenia Drug Results Offset Mixed Earnings - Barrons
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Ltd. Stock Jumps 5.5 percent Will It Continue to Soar - Yahoo New Zea...
Google News at Macroaxis
over six months ago at news.google.com         
Q3 2025 Earnings Forecast for Teva Pharmaceutical Industries Limited Issued By Zacks Research - Mark...
Google News at Macroaxis
over six months ago at news.google.com         
abrdn plc Grows Stock Position in Teva Pharmaceutical Industries Limited - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries 50-Day SMA 12.45 - GuruFocus.com
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Ltd. Gains As Market Dips What You Should Know - Yahoo Movies UK
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited to Post Q2 2025 Earnings of 0.57 Per Share, Zacks Research .....
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Revamps Financial Reporting Structure - TipRanks.com - TipRanks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account